Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Effects of flexibility of the α2 chain of type I collagen on collagenase cleavage.

Mekkat A, Poppleton E, An B, Visse R, Nagase H, Kaplan DL, Brodsky B, Lin YS.

J Struct Biol. 2018 May 12. pii: S1047-8477(18)30117-5. doi: 10.1016/j.jsb.2018.05.002. [Epub ahead of print]

PMID:
29763735
2.

Distinct biological events generated by ECM proteolysis by two homologous collagenases.

Solomonov I, Zehorai E, Talmi-Frank D, Wolf SG, Shainskaya A, Zhuravlev A, Kartvelishvily E, Visse R, Levin Y, Kampf N, Jaitin DA, David E, Amit I, Nagase H, Sagi I.

Proc Natl Acad Sci U S A. 2016 Sep 27;113(39):10884-9. doi: 10.1073/pnas.1519676113. Epub 2016 Sep 14.

3.

Engineered Tissue Inhibitor of Metalloproteinases-3 Variants Resistant to Endocytosis Have Prolonged Chondroprotective Activity.

Doherty CM, Visse R, Dinakarpandian D, Strickland DK, Nagase H, Troeberg L.

J Biol Chem. 2016 Oct 14;291(42):22160-22172. Epub 2016 Aug 31.

4.

MMP-13 is constitutively produced in human chondrocytes and co-endocytosed with ADAMTS-5 and TIMP-3 by the endocytic receptor LRP1.

Yamamoto K, Okano H, Miyagawa W, Visse R, Shitomi Y, Santamaria S, Dudhia J, Troeberg L, Strickland DK, Hirohata S, Nagase H.

Matrix Biol. 2016 Dec;56:57-73. doi: 10.1016/j.matbio.2016.03.007. Epub 2016 Apr 12.

5.

The recognition of collagen and triple-helical toolkit peptides by MMP-13: sequence specificity for binding and cleavage.

Howes JM, Bihan D, Slatter DA, Hamaia SW, Packman LC, Knauper V, Visse R, Farndale RW.

J Biol Chem. 2014 Aug 29;289(35):24091-101. doi: 10.1074/jbc.M114.583443. Epub 2014 Jul 9.

6.

One-pot three-component synthesis and photophysical characteristics of novel triene merocyanines.

Muschelknautz C, Visse R, Nordmann J, Müller TJ.

Beilstein J Org Chem. 2014 Mar 5;10:599-612. doi: 10.3762/bjoc.10.51. eCollection 2014.

7.

Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain.

Stura EA, Visse R, Cuniasse P, Dive V, Nagase H.

FASEB J. 2013 Nov;27(11):4395-405. doi: 10.1096/fj.13-233601. Epub 2013 Aug 2.

8.

Structural insights into triple-helical collagen cleavage by matrix metalloproteinase 1.

Manka SW, Carafoli F, Visse R, Bihan D, Raynal N, Farndale RW, Murphy G, Enghild JJ, Hohenester E, Nagase H.

Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12461-6. doi: 10.1073/pnas.1204991109. Epub 2012 Jul 3.

9.

Defining requirements for collagenase cleavage in collagen type III using a bacterial collagen system.

Yu Z, Visse R, Inouye M, Nagase H, Brodsky B.

J Biol Chem. 2012 Jun 29;287(27):22988-97. doi: 10.1074/jbc.M112.348979. Epub 2012 May 9.

10.

Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.

La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E.

Eur J Med Chem. 2012 Jan;47(1):143-52. doi: 10.1016/j.ejmech.2011.10.035. Epub 2011 Oct 25.

PMID:
22088955
11.

The dimer interface of the membrane type 1 matrix metalloproteinase hemopexin domain: crystal structure and biological functions.

Tochowicz A, Goettig P, Evans R, Visse R, Shitomi Y, Palmisano R, Ito N, Richter K, Maskos K, Franke D, Svergun D, Nagase H, Bode W, Itoh Y.

J Biol Chem. 2011 Mar 4;286(9):7587-600. doi: 10.1074/jbc.M110.178434. Epub 2010 Dec 30.

12.

Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications.

Lim NH, Kashiwagi M, Visse R, Jones J, Enghild JJ, Brew K, Nagase H.

Biochem J. 2010 Oct 1;431(1):113-22. doi: 10.1042/BJ20100725.

13.

Molecular mechanism of type I collagen homotrimer resistance to mammalian collagenases.

Han S, Makareeva E, Kuznetsova NV, DeRidder AM, Sutter MB, Losert W, Phillips CL, Visse R, Nagase H, Leikin S.

J Biol Chem. 2010 Jul 16;285(29):22276-81. doi: 10.1074/jbc.M110.102079. Epub 2010 May 12.

14.

Carcinomas contain a matrix metalloproteinase-resistant isoform of type I collagen exerting selective support to invasion.

Makareeva E, Han S, Vera JC, Sackett DL, Holmbeck K, Phillips CL, Visse R, Nagase H, Leikin S.

Cancer Res. 2010 Jun 1;70(11):4366-74. doi: 10.1158/0008-5472.CAN-09-4057. Epub 2010 May 11.

15.

N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.

Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A.

J Med Chem. 2009 Aug 13;52(15):4757-73. doi: 10.1021/jm900261f.

PMID:
19606871
16.

Catalytic properties of ADAM12 and its domain deletion mutants.

Jacobsen J, Visse R, Sørensen HP, Enghild JJ, Brew K, Wewer UM, Nagase H.

Biochemistry. 2008 Jan 15;47(2):537-47. Epub 2007 Dec 15.

PMID:
18081311
17.

The roles of substrate thermal stability and P2 and P1' subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity.

Minond D, Lauer-Fields JL, Cudic M, Overall CM, Pei D, Brew K, Visse R, Nagase H, Fields GB.

J Biol Chem. 2006 Dec 15;281(50):38302-13. Epub 2006 Oct 25.

18.

Crystal structure of an active form of human MMP-1.

Iyer S, Visse R, Nagase H, Acharya KR.

J Mol Biol. 2006 Sep 8;362(1):78-88. Epub 2006 Aug 4.

19.

Structure and function of matrix metalloproteinases and TIMPs.

Nagase H, Visse R, Murphy G.

Cardiovasc Res. 2006 Feb 15;69(3):562-73. Epub 2006 Jan 5. Review.

PMID:
16405877
20.

X-ray structure of human proMMP-1: new insights into procollagenase activation and collagen binding.

Jozic D, Bourenkov G, Lim NH, Visse R, Nagase H, Bode W, Maskos K.

J Biol Chem. 2005 Mar 11;280(10):9578-85. Epub 2004 Dec 15.

21.

Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis.

Chung L, Dinakarpandian D, Yoshida N, Lauer-Fields JL, Fields GB, Visse R, Nagase H.

EMBO J. 2004 Aug 4;23(15):3020-30. Epub 2004 Jul 15.

22.

Matrix metalloproteinase 1 interacts with neuronal integrins and stimulates dephosphorylation of Akt.

Conant K, St Hillaire C, Nagase H, Visse R, Gary D, Haughey N, Anderson C, Turchan J, Nath A.

J Biol Chem. 2004 Feb 27;279(9):8056-62. Epub 2003 Dec 15.

23.
24.

The role of ATP binding and hydrolysis by UvrB during nucleotide excision repair.

Moolenaar GF, Herron MF, Monaco V, van der Marel GA, van Boom JH, Visse R, Goosen N.

J Biol Chem. 2000 Mar 17;275(11):8044-50.

25.

The effect of the DNA flanking the lesion on formation of the UvrB-DNA preincision complex. Mechanism for the UvrA-mediated loading of UvrB onto a DNA damaged site.

Moolenaar GF, Monaco V, van der Marel GA, van Boom JH, Visse R, Goosen N.

J Biol Chem. 2000 Mar 17;275(11):8038-43.

26.

Catalytic sites for 3' and 5' incision of Escherichia coli nucleotide excision repair are both located in UvrC.

Verhoeven EE, van Kesteren M, Moolenaar GF, Visse R, Goosen N.

J Biol Chem. 2000 Feb 18;275(7):5120-3.

27.

Crystal structure of Escherichia coli UvrB C-terminal domain, and a model for UvrB-uvrC interaction.

Sohi M, Alexandrovich A, Moolenaar G, Visse R, Goosen N, Vernede X, Fontecilla-Camps JC, Champness J, Sanderson MR.

FEBS Lett. 2000 Jan 14;465(2-3):161-4.

28.

Synthesis and biological evaluation of modified DNA fragments for the study of nucleotide excision repair in E. coli.

Monaco V, van de Wetering KI, Meeuwenoord NJ, van den Elst HA, Stuivenberg HR, Visse R, van der Kaaden JC, Moolenaar GF, Verhoeven EE, Goosen N, van der Marel GA, van Boom JH.

Nucleosides Nucleotides. 1999 Jun-Jul;18(6-7):1339-41.

PMID:
10474222
29.

Characterization of the rhp7(+) and rhp16(+) genes in Schizosaccharomyces pombe.

Lombaerts M, Peltola PH, Visse R, den Dulk H, Brandsma JA, Brouwer J.

Nucleic Acids Res. 1999 Sep 1;27(17):3410-6.

30.

Characterization of the Escherichia coli damage-independent UvrBC endonuclease activity.

Moolenaar GF, Bazuine M, van Knippenberg IC, Visse R, Goosen N.

J Biol Chem. 1998 Dec 25;273(52):34896-903.

31.

Exploring the active site of herpes simplex virus type-1 thymidine kinase by X-ray crystallography of complexes with aciclovir and other ligands.

Champness JN, Bennett MS, Wien F, Visse R, Summers WC, Herdewijn P, de Clerq E, Ostrowski T, Jarvest RL, Sanderson MR.

Proteins. 1998 Aug 15;32(3):350-61.

PMID:
9715911
32.

The in vitro more efficiently repaired cisplatin adduct cis-Pt.GG is in vivo a more mutagenic lesion than the relative slowly repaired cis-Pt.GCG adduct.

Brandsma JA, de Ruijter M, Visse R, van Meerten D, van der Kaaden M, Moggs JG, van de Putte P.

Mutat Res. 1996 Jan 2;362(1):29-40.

PMID:
8538646
33.

The C-terminal region of the UvrB protein of Escherichia coli contains an important determinant for UvrC binding to the preincision complex but not the catalytic site for 3'-incision.

Moolenaar GF, Franken KL, Dijkstra DM, Thomas-Oates JE, Visse R, van de Putte P, Goosen N.

J Biol Chem. 1995 Dec 22;270(51):30508-15.

34.

Crystal structures of the thymidine kinase from herpes simplex virus type-1 in complex with deoxythymidine and ganciclovir.

Brown DG, Visse R, Sandhu G, Davies A, Rizkallah PJ, Melitz C, Summers WC, Sanderson MR.

Nat Struct Biol. 1995 Oct;2(10):876-81.

PMID:
7552712
35.
36.

DNA repair by UvrABC. In vitro analysis of the preincision complex.

Visse R, Moolenaar GF, de Ruijter M, van de Putte P.

Ann N Y Acad Sci. 1994 Jul 29;726:327-9. Review. No abstract available.

PMID:
8092695
37.

Helicase motifs V and VI of the Escherichia coli UvrB protein of the UvrABC endonuclease are essential for the formation of the preincision complex.

Moolenaar GF, Visse R, Ortiz-Buysse M, Goosen N, van de Putte P.

J Mol Biol. 1994 Jul 22;240(4):294-307.

PMID:
8035457
38.

The actual incision determines the efficiency of repair of cisplatin-damaged DNA by the Escherichia coli UvrABC endonuclease.

Visse R, van Gool AJ, Moolenaar GF, de Ruijter M, van de Putte P.

Biochemistry. 1994 Feb 22;33(7):1804-11.

PMID:
8110782
39.

The first zinc-binding domain of UvrA is not essential for UvrABC-mediated DNA excision repair.

Visse R, de Ruijter M, Ubbink M, Brandsma JA, van de Putte P.

Mutat Res. 1993 Oct;294(3):263-74.

PMID:
7692266
40.

Analysis of UvrABC endonuclease reaction intermediates on cisplatin-damaged DNA using mobility shift gel electrophoresis.

Visse R, de Ruijter M, Moolenaar GF, van de Putte P.

J Biol Chem. 1992 Apr 5;267(10):6736-42.

41.

Uvr excision repair protein complex of Escherichia coli binds to the convex side of a cisplatin-induced kink in the DNA.

Visse R, de Ruijter M, Brouwer J, Brandsma JA, van de Putte P.

J Biol Chem. 1991 Apr 25;266(12):7609-17.

42.

Assignment of the human tissue-type plasminogen activator gene (PLAT) to chromosome 8.

Verheijen JH, Visse R, Wijnen JT, Chang GT, Kluft C, Meera Khan P.

Hum Genet. 1986 Feb;72(2):153-6.

PMID:
3002960

Supplemental Content

Support Center